These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 17003321)

  • 1. Reversibility of antipsychotic treatment-related diabetes in patients with schizophrenia: a case series of switching to aripiprazole.
    De Hert M; Hanssens L; van Winkel R; Wampers M; Van Eyck D; Scheen A; Peuskens J
    Diabetes Care; 2006 Oct; 29(10):2329-30. PubMed ID: 17003321
    [No Abstract]   [Full Text] [Related]  

  • 2. Metabolic impact of switching antipsychotic therapy to aripiprazole after weight gain: a pilot study.
    Kim SH; Ivanova O; Abbasi FA; Lamendola CA; Reaven GM; Glick ID
    J Clin Psychopharmacol; 2007 Aug; 27(4):365-8. PubMed ID: 17632220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of Aripiprazole in treatment resistant schizophrenia.
    Hughes D; Morcos M
    J Psychopharmacol; 2008 Nov; 22(8):927-8. PubMed ID: 18308805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of switching from aripiprazole to ziprasidone in patients with schizophrenia.
    Kim SW; Shin IS; Kim JM; Bae KY; Yang SJ; Yoon JS
    Clin Neuropharmacol; 2010 May; 33(3):121-5. PubMed ID: 20502130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperhidrosis under combination of zotepine and haloperidol alleviated by aripiprazole.
    Huang WL; Chang LR
    Psychiatry Clin Neurosci; 2012 Apr; 66(3):245. PubMed ID: 22443252
    [No Abstract]   [Full Text] [Related]  

  • 6. A case of Aripiprazole and extra pyramidal side effects.
    Salmoiraghi A; Odiyoor M
    J Psychopharmacol; 2006 Jul; 20(4):592-3. PubMed ID: 16401661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time course of the changes in antipsychotic-induced hyperprolactinemia following the switch to aripiprazole.
    Lu ML; Shen WW; Chen CH
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1978-81. PubMed ID: 18848860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aripiprazole: pharmacology, efficacy, safety and tolerability.
    Kinghorn WA; McEvoy JP
    Expert Rev Neurother; 2005 May; 5(3):297-307. PubMed ID: 15938662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful monotherapy treatment with aripiprazole in a patient with schizophrenia and prolactinoma.
    Freeman B; Levy W; Gorman JM
    J Psychiatr Pract; 2007 Mar; 13(2):120-4. PubMed ID: 17414690
    [No Abstract]   [Full Text] [Related]  

  • 10. The patient with schizophrenia taking aripiprazole: case report.
    Uzun S; Kozumplik O; Mimica N; Folnegović-Smalc V
    Psychiatr Danub; 2005 Dec; 17(3-4):234-5. PubMed ID: 16392433
    [No Abstract]   [Full Text] [Related]  

  • 11. Aripiprazole in chronic schizophrenia: experiences in daily practice.
    Fernald DS; van Dellen RT; Hovens JE; Loonen AJ
    Acta Psychiatr Scand; 2006 Oct; 114(4):294; author reply 294. PubMed ID: 16968370
    [No Abstract]   [Full Text] [Related]  

  • 12. Comment on "dose-dependent effects of adjunctive treatment with aripiprazole on hyperprolactinemia induced by risperidone in female patients with schizophrenia".
    Ishitobi M; Kosaka H; Shukunami K; Murata T; Wada Y
    J Clin Psychopharmacol; 2011 Jun; 31(3):400-1; author reply 401. PubMed ID: 21532377
    [No Abstract]   [Full Text] [Related]  

  • 13. Aripiprazole use in individuals with intellectual disability and psychotic or behavioural disorders: a case series.
    Shastri M; Alla L; Sabaratnam M
    J Psychopharmacol; 2006 Nov; 20(6):863-7. PubMed ID: 16891339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aripiprazole in treatment-refractory schizophrenia.
    Hsu WY; Lee CI; Chiu NY; Kahn DA
    J Psychiatr Pract; 2009 May; 15(3):221-6. PubMed ID: 19461396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aripiprazole in schizophrenia: consensus guidelines.
    Travis MJ; Burns T; Dursun S; Fahy T; Frangou S; Gray R; Haddad PM; Hunter R; Taylor DM; Young AH
    Int J Clin Pract; 2005 Apr; 59(4):485-95. PubMed ID: 15853869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement of serum prolactin and sexual function after switching to aripiprazole from risperidone in schizophrenia: a case series.
    Chen CY; Lin TY; Wang CC; Shuai HA
    Psychiatry Clin Neurosci; 2011 Feb; 65(1):95-7. PubMed ID: 21265942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aripiprazole. The newest antipsychotic agent for treatment of schizophrenia.
    Bailey KP
    J Psychosoc Nurs Ment Health Serv; 2003 Feb; 41(2):14-8. PubMed ID: 12613095
    [No Abstract]   [Full Text] [Related]  

  • 18. High dosage of aripiprazole-induced dysphagia.
    Lin TW; Lee BS; Liao YC; Chiu NY; Hsu WY
    Int J Eat Disord; 2012 Mar; 45(2):305-6. PubMed ID: 21541978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clozapine augmented with aripiprazole in 5 patients with schizophrenia.
    Abu-Tair F; Kopitz J; Bergemann N
    J Clin Psychopharmacol; 2006 Dec; 26(6):669-71. PubMed ID: 17110831
    [No Abstract]   [Full Text] [Related]  

  • 20. Trial of aripiprazole in the treatment of first-episode schizophrenia.
    Lee HY; Ham BJ; Kang RH; Paik JW; Hahn SW; Lee MS; Lee MS
    Psychiatry Clin Neurosci; 2010 Feb; 64(1):38-43. PubMed ID: 20416024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.